SELLAS Life Sciences (SLS) Cash & Equivalents (2019 - 2024)
Historic Cash & Equivalents for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to $21.0 million.
- SELLAS Life Sciences' Cash & Equivalents rose 42577.5% to $21.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $21.0 million, marking a year-over-year increase of 42577.5%. This contributed to the annual value of $2.5 million for FY2023, which is 8522.63% down from last year.
- As of Q3 2024, SELLAS Life Sciences' Cash & Equivalents stood at $21.0 million, which was up 42577.5% from $9.1 million recorded in Q2 2024.
- Over the past 5 years, SELLAS Life Sciences' Cash & Equivalents peaked at $35.3 million during Q4 2020, and registered a low of $2.5 million during Q4 2023.
- Over the past 5 years, SELLAS Life Sciences' median Cash & Equivalents value was $18.4 million (recorded in 2024), while the average stood at $17.5 million.
- Per our database at Business Quant, SELLAS Life Sciences' Cash & Equivalents soared by 79571.86% in 2021 and then crashed by 8522.63% in 2023.
- Over the past 5 years, SELLAS Life Sciences' Cash & Equivalents (Quarter) stood at $35.3 million in 2020, then plummeted by 39.51% to $21.4 million in 2021, then fell by 19.81% to $17.1 million in 2022, then crashed by 85.23% to $2.5 million in 2023, then skyrocketed by 731.26% to $21.0 million in 2024.
- Its Cash & Equivalents stands at $21.0 million for Q3 2024, versus $9.1 million for Q2 2024 and $18.4 million for Q1 2024.